Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |